GSC
ELOS

Ground Swell Capital’s Syneron Medical Ltd ELOS Stock Holding History

Ground Swell Capital’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3K Buy
+281
New +$2.86K 0.01% 1813

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Ground Swell Capital's ELOS Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Syneron Medical Ltd (ELOS) in Q3 2014: 281 shares worth $3K. The stake represents 0.01% of the portfolio and ranks #1813 among its holdings.

65 funds tracked by Wall St. Rank hold ELOS as of Q3 2014.

  • Ground Swell Capital held 281 shares of Syneron Medical Ltd worth $3K as of Q3 2014.
  • Syneron Medical Ltd was a new Ground Swell Capital position in Q3 2014.
  • Syneron Medical Ltd made up 0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1813 holding.
  • 65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.